Talis Biomedical Corp. (TLIS)

Sector:Health Care
Super Investor Stats:
Ownership count:1
Ownership rank:662
% of all portfolios:0.001%
History Portfolio Manager Activity Share change % change to portfolio
Q3  2023
David Einhorn - Greenlight Capital Add 0.00% 1 0.00
Q1  2022
David Einhorn - Greenlight Capital Add 42.47% 44,432 0.06
Q4  2021
David Einhorn - Greenlight Capital Buy 104,620 0.38
Q2  2021
Meridian Contrarian Fund Add 26.26% 6,666 0.15
Q1  2021
Meridian Contrarian Fund Buy 25,388 0.71

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.